Showing results (351-360 of 403) with videos related to

Sort By:
Pageof 41
Oncogene|October 31, 2012
The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatmentL J Monteiro, P Khongkow, M Kongsema, et al.
International Journal of Oncology|June 11, 2009
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancerRichard E Francis, Stephen S Myatt, Janna Krol, et al.
Nucleic Acids Research|April 13, 2013
miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcriptsLoredana Pellegrino, Justin Stebbing, Vania M Braga, et al.
Nucleic Acids Research|October 5, 2017
p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cellsManikandan Periyasamy, Anup K Singh, Carolina Gemma, et al.
Molecular Cancer Therapeutics|March 17, 2018
ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer TreatmentHetal Patel, Manikandan Periyasamy, Georgina P Sava, et al.
Nature Medicine|May 24, 2011
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancerGeorgios Giamas, Aleksandra Filipović, Jimmy Jacob, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2015
SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast CancerWilbert Zwart, Koen D Flach, Bharath Rudraraju, et al.
Breast Cancer Research and Treatment|September 25, 2014
Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cellsAleksandra Filipović, Ylenia Lombardo, Monica Faronato, et al.
Nucleic Acids Research|September 20, 2013
Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cellsChun-Fui Lai, Koen D Flach, Xanthippi Alexi, et al.
Nature Communications|November 28, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Pageof 41